产品展厅收藏该商铺

您好 登录 注册

当前位置:
美国布鲁克海文仪器公司>资料下载>测量应用案例-2020102

资料下载

测量应用案例-2020102

阅读:187          发布时间:2020-1-13
提 供 商 美国布鲁克海文仪器公司 资料大小 1.6MB
资料图片 下载次数 27次
资料类型 PDF 文件 浏览次数 187次
免费下载 点击下载    

文献名:Multiple-Exposure Drug Release from Stable Nanodroplets by High-Intensity Focused Ultrasound for a Potential Degenerative Disc Disease Treatment 

 

作者Khoi Nguyen*, Hsuan-Yeh Pan†, Kevin Haworth*†, Eric Mahoney*, Karla P. Mercado-Shekhar†, Chia-Ying Lin‡, Zhe Zhang§, Yoonjee C. Park*

*    Department of Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio, USA

    Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA

    Department of Orthopaedic Surgery, University of Cincinnati, Cincinnati, Ohio, USA

§  Department of Chemical & Environmental Engineering, University of Cincinnati, Cincinnati, Ohio, USA

 

摘要:The combination of simvastatin and CF680 dye encapsulated by stable nanodroplets has been developed as a drug delivery carrier. Simvastatin has previously been found to be a potential degenerative disc disease treatment. Multiple exposures of the nanodroplets to high-intensity focused ultrasound induced release of simvastatin. Each ultrasound exposure yielded a consistent concentration of the drug and dye released. B-mode ultrasound image analysis data and cavitation data clearly indicated the release mechanism is phase transition of the liquid nanodroplets into gas bubbles. The nanodroplets were stably stored in ex vivo rabbit spinal discs for at least 14 days, and the contents responded to ultrasound exposure on demand. Lastly, nucleus pulposus cells harvested from rabbit spine discs and exposed to media with nanodroplets exhibited a decrease in cell viability (85%) relative to the cells only (96.7%) at 24 h, but no difference at 48 h. Thus, the system may be a potential degenerative disc disease treatment.

收藏该商铺

登录 后再收藏

提示

您的留言已提交成功!我们将在第一时间回复您~

对比框

产品对比 产品对比 联系电话 二维码 意见反馈 在线交流

扫一扫访问手机商铺
010-62081908
在线留言